Cleared Traditional

K163119 - NaviSuite SSI Edition

K163119 is an FDA 510(k) clearance for NaviSuite SSI Edition, manufactured by Medcom GmbH. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 174-day FDA review.

K163119 · Medcom GmbH · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2017
Decision
174d
Days
Class 2
Risk

K163119 is an FDA 510(k) clearance for the NaviSuite SSI Edition. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Medcom GmbH (Darmstadt, DE). The FDA issued a Cleared decision on May 1, 2017 after a review of 174 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Medcom GmbH devices

FDA 510(k) Submission Details - K163119

510(k) Number K163119 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 2016
Decision Date May 01, 2017
Days to Decision 174 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
67d slower than avg
Panel avg: 107d · This submission: 174d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1858
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K163119.
Will3D
K170180 · Hdx Will Corp. · May 2017
Nucleus Image Management System
K171130 · Nucleushealth, LLC · May 2017
NuVasive NuvaLine Mobile App
K162647 · Nu Vasive, Incorporated · May 2017
syngo.CT View&GO
K170952 · Siemens Medical Solutions USA, Inc. · Apr 2017
AmCAD-UV
K170069 · Amcad Biomed Corporation · Apr 2017
Cliniview
K162799 · Palodex Group OY · Apr 2017